Another way to target VCAM-1 is to exploit peptides that are characterized by high affinity and specificity for VCAM-1 binding: several research groups developed VCAM-1 targeting systems for the diagnosis and therapy of atherosclerosis and cancer, by exploiting VCAM-1 targeting peptides [10]. This evidence concerns the gene VCAM1 and atherosclerosis.